Qube Research & Technologies (QRT)’s OrthoPediatrics KIDS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,392	Closed	-$256K	–	3849
2025 Q4	$256K	Buy	+14,392	New	+$252K	﹤0.01%	3000
2024 Q2	–	Sell	-4,359	Closed	-$127K	–	4312
2024 Q1	$127K	Sell	4,359 -1,788	-29%	-$50K	﹤0.01%	3213
2023 Q4	$200K	Buy	6,147 +182	+3%	+$5.28K	﹤0.01%	2789
2023 Q3	$191K	Buy	5,965 +547	+10%	+$21.1K	﹤0.01%	2427
2023 Q2	$238K	Buy	5,418 +844	+18%	+$38.9K	﹤0.01%	1731
2023 Q1	$203K	Sell	4,574 -16,926	-79%	-$748K	﹤0.01%	1935
2022 Q4	$854K	Buy	+21,500	New	+$896K	﹤0.01%	1290
2021 Q1	–	Sell	-4,928	Closed	-$203K	–	2174
2020 Q4	$203K	Buy	+4,928	New	+$226K	﹤0.01%	1528

Other funds holding KIDS

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KIDS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of OrthoPediatrics (KIDS) in Q1 2026, closing a stake of 14,392 shares — an estimated $256K sold.

Qube Research & Technologies (QRT) first reported a position in KIDS in Q4 2020 and held it in 8 quarters. The position peaked at $854K in Q4 2022. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining OrthoPediatrics position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 14,392 OrthoPediatrics shares in Q1 2026, an estimated $256K.
Qube Research & Technologies (QRT) first reported a position in OrthoPediatrics in Q4 2020 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s OrthoPediatrics position peaked at $854K in Q4 2022.
121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.